17 October 2017
Project to prevent cerebral palsy in premature babies wins funding
Developed in maternity units across
the West of England, the 'PReCePT' project has been selected by the
Health Foundation to be part of an ambitious £3.5 million
improvement programme.
The Scaling Up Improvement programme is supporting seven
projects in the UK to take their proven health care interventions
and approaches and make them work at larger scale to have a
positive impact on patient outcomes.
PReCePT, which stands for the Prevention of Cerebral Palsy in
PreTerm Labour, has been designed to help reduce cerebral palsy in
babies by administering magnesium sulphate (MgSO4) to
mothers during preterm labour, at a cost of around £1 per
individual dose.
Preterm birth is the leading cause of brain injury and cerebral
palsy, which has a lifelong impact on children and families.
NICE recommends administration of MgSO4 in preterm
deliveries to substantially reduce the risk of cerebral palsy by
30%, based on evidence in support of its brain protective
potential. However, the uptake of MgSO4 in the UK remains
relatively low, compared with the leading countries in the
developed world.
The PReCePT initiative was developed by University Hospitals
Bristol NHS Foundation Trust in collaboration with the West of
England Academic Health Science Network (AHSN), and co-designed
with both patients and staff. The NIHR Collaboration for Leadership
in Applied Health and Care (CLAHRC) West is evaluating the
initiative.
Providing a comprehensive package of training and support
materials, the intervention was rolled out to all five maternity
units in the West of England (St Michael's Hospital, Bristol;
Gloucestershire Royal Hospital; Great Western Hospital - Swindon;
Southmead Hospital - Bristol; and Royal United Hospital - Bath). It
is estimated that this first phase of PReCePT has so far prevented
five to ten cases of cerebral palsy across the region, representing
potential lifetime healthcare savings in the region of £5 million
and substantially more when including loss of productivity and
social care costs over a lifetime.
As a result of the £0.5 million Scaling Up funding from the
Health Foundation, support can now be provided to a further 10
hospital trusts around the country to implement PReCePT in their
maternity units, covering the South, North West and South West of
England, Midlands, Wales and London.
NIHR CLAHRC West will carry out a full evaluation of the wider
roll-out of PReCePT and it is hoped that this will inform future
spread across all maternity units. If rolled out nationally, it is
estimated that up to 14,000 low birthweight babies could benefit
from this intervention each year.
Dr Karen Luyt is a Consultant in Neonatal Medicine at St
Michael's Hospital, which is part of University Hospitals Bristol
NHS Foundation Trust, and has been the project lead for PReCePT
since it was first launched in 2014.
Dr Luyt said: "Magnesium sulphate is a very cost effective way
to prevent brain injury in babies that are born early. We have
already demonstrated that this evidence-based intervention can be
put into practice rapidly and be sustained when supported by
quality improvement (QI) methodology. Our aim with PReCePT2 is to
scale up across the UK, ultimately making this potentially life
changing intervention consistently available for every eligible
preterm delivery."
University Hospitals Bristol will lead this next phase to scale
up PReCePT to 10 further trusts, working in partnership with a wide
range of organisations, including:
- NIHR CLAHRC West (evaluation partner)
- People in Health West of England (patient and public
involvement)
- West of England AHSN (training and support)
- Innovation Agency - AHSN for the North West Coast (supporting
rollout to maternity units in the North West)
The Health Foundation's Scaling Up programme will run for two
and a half years and each project will receive up to £0.5 million
of funding to put their project into practice and evaluate it.
Sarah Henderson, Associate Director from the Health Foundation
said: "We are very excited to support seven outstanding project
teams who have been selected because of their expertise in scaling
complex improvement projects, and their ambition to achieve impact
by improving care for patients.
"Working together, as part of the Scaling Up programme, we aim
to make sustained improvements to health care by testing out proven
interventions at a scale. We hope to see the interventions being
widely adopted across the UK."
BACK TO NEWS